Literature DB >> 11438461

Morphological interactions of interdigitating dendritic cells with B and T cells in human mesenteric lymph nodes.

K Takahashi1, A Kenji, T Norihiro, K Eisaku, O Takashi, H Kazuhiko, Y Tadashi, A Tadaatsu.   

Abstract

Interdigitating dendritic cells (IDC) of the human mesenteric lymph nodes (LN) were examined by two-color immunofluorescent microscopy and flow cytometry to clarify their exact localization, immunophenotype, and relationships with T and B cells. IDC were identified as HLA-DR(bright) large dendriform cells of the T cell areas co-expressing CD40, CD54 (ICAM-1), CD80 (B7/B7-1), CD83, and CD86 (B70/B7-2). The majority of IDC directly attached to a few IgD+ naive B cells as well as to numerous CD4+ T cells. When LN cells were singly suspended and briefly incubated in vitro, IDC formed clusters with IgD+ IgM+ naive B cells, but not with IgA+ or IgG+ B cells. When suspended LN cells were cultured, clustered B cells disappeared within 7 days, and on prolonged culture, some IDC developed into extensively dendriform cells forming stable complexes with several or sometimes numerous CD4+ IL-2R+ CD40L+ activated T cells. These findings indicate that resting naive B cells actually interact with IDC directly in T cell areas of human secondary lymphoid tissues. IDC have a non-antigen (Ag)-specific, strong affinity for resting naive B cells, but this affinity is transient and IDC cannot form stable complexes with B cells, although they can form stable complexes with activated T cells. It is suggested that the stable IDC/Ag-activated T cell complexes make it possible to capture and to stimulate rare Ag-specific resting naive B cells with high efficiency.

Entities:  

Mesh:

Year:  2001        PMID: 11438461      PMCID: PMC1850413          DOI: 10.1016/S0002-9440(10)61680-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens.

Authors:  Y J Liu; J Zhang; P J Lane; E Y Chan; I C MacLennan
Journal:  Eur J Immunol       Date:  1991-12       Impact factor: 5.532

2.  Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation.

Authors:  L M Pinchuk; S J Klaus; D M Magaletti; G V Pinchuk; J P Norsen; E A Clark
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

Review 3.  Functional CD40 on B lymphocytes and dendritic cells.

Authors:  C Caux; N Burdin; L Galibert; P Hermann; N Renard; C Servet-Delprat; J Banchereau
Journal:  Res Immunol       Date:  1994 Mar-Apr

4.  Dendritic cells capable of stimulating T cells in germinal centres.

Authors:  G Grouard; I Durand; L Filgueira; J Banchereau; Y J Liu
Journal:  Nature       Date:  1996-11-28       Impact factor: 49.962

5.  Recruitment of virgin B cells into an immune response is restricted to activation outside lymphoid follicles.

Authors:  D Gray
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

6.  Functional CD40 ligand is expressed on epidermal Langerhans cells.

Authors:  C G Salgado; K Nakamura; M Sugaya; Y Tada; A Asahina; Y Koyama; S Irie; K Tamaki
Journal:  J Leukoc Biol       Date:  1999-08       Impact factor: 4.962

7.  CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells.

Authors:  P Björck; J Banchereau; L Flores-Romo
Journal:  Int Immunol       Date:  1997-03       Impact factor: 4.823

8.  Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation.

Authors:  M Cella; D Scheidegger; K Palmer-Lehmann; P Lane; A Lanzavecchia; G Alber
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

9.  Regulation of B lymphocytes by dendritic cells.

Authors:  E A Clark
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

10.  In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations.

Authors:  J Jacob; R Kassir; G Kelsoe
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  11 in total

1.  Sampling tumor-draining lymph nodes for phenotypic and functional analysis of dendritic cells and T cells.

Authors:  Ronald J C L M Vuylsteke; Paul A M van Leeuwen; Sybren Meijer; Pepijn G J T B Wijnands; Markwin G Statius Muller; Dirk H Busch; Rik J Scheper; Tanja D de Gruijl
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

2.  Dendritic cell populations in colon and mesenteric lymph nodes of patients with Crohn's disease.

Authors:  Marleen I Verstege; Fiebo J W ten Kate; Susanne M Reinartz; Cornelis M van Drunen; Frederik J M Slors; Willem A Bemelman; Florry A Vyth-Dreese; Anje A te Velde
Journal:  J Histochem Cytochem       Date:  2007-11-26       Impact factor: 2.479

3.  A comparison of random vs. chemotaxis-driven contacts of T cells with dendritic cells during repertoire scanning.

Authors:  Thomas Riggs; Adrienne Walts; Nicolas Perry; Laura Bickle; Jennifer N Lynch; Amy Myers; Joanne Flynn; Jennifer J Linderman; Mark J Miller; Denise E Kirschner
Journal:  J Theor Biol       Date:  2007-10-18       Impact factor: 2.691

4.  Dendritic cells interacting mainly with B cells in the lymphoepithelial symbiosis of the human palatine tonsil.

Authors:  Kiyoshi Takahashi; Yuriko Nishikawa; Hiaki Sato; Takashi Oka; Tadashi Yoshino; Katsuya Miyatani
Journal:  Virchows Arch       Date:  2006-03-08       Impact factor: 4.064

5.  Presentation of soluble antigens to CD8+ T cells by CpG oligodeoxynucleotide-primed human naive B cells.

Authors:  Wei Jiang; Michael M Lederman; Clifford V Harding; Scott F Sieg
Journal:  J Immunol       Date:  2011-01-14       Impact factor: 5.422

6.  Characterizing the dynamics of CD4+ T cell priming within a lymph node.

Authors:  Jennifer J Linderman; Thomas Riggs; Manjusha Pande; Mark Miller; Simeone Marino; Denise E Kirschner
Journal:  J Immunol       Date:  2010-02-12       Impact factor: 5.422

7.  Targeting MARCO can lead to enhanced dendritic cell motility and anti-melanoma activity.

Authors:  Norimasa Matsushita; Hiroshi Komine; Annabelle Grolleau-Julius; Shari Pilon-Thomas; James J Mulé
Journal:  Cancer Immunol Immunother       Date:  2010-01-08       Impact factor: 6.968

8.  Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy.

Authors:  Qian Chen; Ligeng Xu; Chao Liang; Chao Wang; Rui Peng; Zhuang Liu
Journal:  Nat Commun       Date:  2016-10-21       Impact factor: 14.919

9.  Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses.

Authors:  Guangbao Yang; Ligeng Xu; Yu Chao; Jun Xu; Xiaoqi Sun; Yifan Wu; Rui Peng; Zhuang Liu
Journal:  Nat Commun       Date:  2017-10-12       Impact factor: 14.919

10.  Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy.

Authors:  Liping Huang; Yanan Li; Yunai Du; Yiyi Zhang; Xiuxia Wang; Yuan Ding; Xiangliang Yang; Fanling Meng; Jiasheng Tu; Liang Luo; Chunmeng Sun
Journal:  Nat Commun       Date:  2019-10-25       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.